G protein-coupled receptor
CB2 receptor
Cannabinoid receptor 2
- GeneCNR2
- FamilyCannabinoid & related receptors
- GroupCannabinoid receptors
The CB2 receptor was cloned from the human leukaemia cell line HL60. In that first study it was found not in the brain but in macrophages of the spleen.1
Like CB1 it inhibits the formation of cyclic AMP, and THC binds both about equally well. Unlike CB1 it did not act on calcium and potassium channels, and the CB1 blocker rimonabant (SR141716A) blocks it poorly.2
CB2 receptors have a more restricted distribution than CB1 receptors. They are found in a number of immune cells and in a few neurones.3 The receptor was first considered the peripheral cannabinoid receptor, based on its abundant expression in the immune system and its presumed absence from the central nervous system. It is now well accepted that it is expressed in brain microglia during neuroinflammation, but the extent of its expression in neurons has remained controversial, with claims ranging from complete absence to widespread expression. The authors of a review recommend cautious interpretation of the data for and against CB2 in neurons.4 In the rat, CB2 receptor messenger RNA was found in the cerebellum, cortex and brainstem, and the brainstem held 1.5 percent of the amount found in the spleen. Immunoreactivity was found in neurons of the dorsal motor nucleus of the vagus, the nucleus ambiguus and the spinal trigeminal nucleus, but not in glial cells or blood vessels. These brainstem receptors were activated by the endocannabinoid 2-arachidonoylglycerol.5 Another group reported CB2 messenger RNA in cerebellar neurons of wild-type but not of CB2 knockout mice. Transcripts in the brain were at levels much lower than those of CB1. The authors suggest that brain CB2 receptors may be involved in depression and drug abuse.6
The first mice with a targeted mutation in the CB2 gene appeared healthy, were fertile and cared for their offspring, and the immune cell populations were not different. Binding of a cannabinoid agonist was absent in their spleen, while binding in the central nervous system was unchanged. THC inhibited the activation of helper T cells through macrophages from normal mice but not from the knockouts, so this effect is mediated by CB2, while the central nervous system effects of cannabinoids were not altered.7
A review suggests that endocannabinoid signalling through CB2 receptors may be part of a protective system. Inflammation and tissue injury trigger rapid rises in local endocannabinoid levels. Changes in endocannabinoid levels or in CB2 expression have been reported in almost all diseases that affect humans. CB2 activation in general mediates immunosuppressive effects that limit inflammation, but in some disease states it may enhance or even trigger tissue damage.8
Sources (8)
- Munro et al. 1993Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids Nature
- Felder et al. 1995Felder CC, Joyce KE, Briley EM, et al. (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors Mol Pharmacol
- Mackie 2008Mackie K (2008) Cannabinoid receptors: where they are and what they do J Neuroendocrinol
- Atwood et al. 2010Atwood BK, Mackie K (2010) CB2: a cannabinoid receptor with an identity crisis Br J Pharmacol
- Van Sickle et al. 2005Van Sickle MD, Duncan M, Kingsley PJ, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors Science
- Onaivi et al. 2006Onaivi ES, Ishiguro H, Gong JP, et al. (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain Ann N Y Acad Sci
- Buckley et al. 2000Buckley NE, McCoy KL, Mezey E, et al. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor Eur J Pharmacol
- Pacher et al. 2011Pacher P, Mechoulam R (2011) Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res
Binding affinity (Kᵢ)
10 substances, 15 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
10 measurements
HU-2101.4 nMGovaerts SophieJ et al. 2004 · 3 reports
- Assay
- CHO cells expressing human CB2, [3H]WIN 55,212-2 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
- Range
- 0.17–1.4 nM in 3 reports
Sources and values behind the range, same assay family Report Value Where Govaerts SophieJ et al. 2004 1.4 nM Table 2 Felder et al. 1995 0.52 nM Table 1 Rhee et al. 1997 0.17 nM Table 1 Nabilone1.8 nMGareau et al. 1996
- Assay
- Human CB2 receptor; [3H](-)CP-55940 displacement (cell system not stated)
- Shown value from
- Gareau et al. 1996, Table 3 (compound 8)
- Error
- ± 0.42 SEM
JWH-0182.9 nMAung et al. 2000
- Assay
- CHO cells expressing cloned human CB2; [3H]CP-55,940 competition binding
- Shown value from
- Aung et al. 2000, Table 1
CP 55,94011 nMGovaerts SophieJ et al. 2004 · 5 reports
- Assay
- CHO cells expressing human CB2, [3H]WIN 55,212-2 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
- Range
- 0.30–29 nM in 5 reports
Reported values disagree and no value is established. 5 reports in all, 0.30–29 nM.
Sources and values behind the range, same assay family Report Value Where Zagzoog et al. 2020 29 nM Table 1 Scott et al. 2019 0.30 nM Table 1 Govaerts SophieJ et al. 2004 11 nM Table 2 Felder et al. 1995 2.5 nM Table 1 Ross et al. 1999 1.8 nM Table 1 WIN 55,212-217 nMGovaerts SophieJ et al. 2004 · 4 reports
- Assay
- CHO cells expressing human CB2, [3H]WIN 55,212-2 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
- Range
- 3.2–17 nM in 4 reports
Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 3.2–17 nM.
Sources and values behind the range, same assay family Report Value Where Govaerts SophieJ et al. 2004 17 nM Table 2 Felder et al. 1995 3.3 nM Table 1 Navarro et al. 2020 3.2 nM, 3.5 nM Table 1 Δ⁸-THC (Tetrahydrocannabinol)50 nMWiley et al. 2024 · 3 reports
- Assay
- HEK293 membranes expressing human CB2; [3H]CP55,940 competition binding
- Shown value from
- Wiley et al. 2024, Table 1
- Range
- 12–417 nM in 3 reports
This is the best-supported value. Other reports differ. 3 reports in all, 12–417 nM.
Sources and values behind the range, same assay family Report Value Where Wiley et al. 2024 50 nM Table 1 Husni et al. 2014 12 nM Table 1 Govaerts SophieJ et al. 2004 417 nM Table 2 Δ⁹-THC (Tetrahydrocannabinol)52 nMWiley et al. 2024 · 7 reports
- Assay
- HEK293 membranes expressing human CB2; [3H]CP55,940 competition binding
- Shown value from
- Wiley et al. 2024, Table 1
- Range
- 31–320 nM in 7 reports
This is the best-supported value. Other reports differ. 8 reports in all, 17–320 nM.
Sources and values behind the range, same assay family Report Value Where Wiley et al. 2024 52 nM Table 1 Husni et al. 2014 42 nM Table 1 Zagzoog et al. 2020 31 nM Table 1 Govaerts SophieJ et al. 2004 309 nM Table 2 Felder et al. 1995 75 nM Table 1 Rhee et al. 1997 32 nM Table 1 Munro et al. 1993 320 nM Results text (Figure 2b) Cannabinol (CBN)163 nMWiley et al. 2024 · 5 reports
- Assay
- HEK293 membranes expressing human CB2; [3H]CP55,940 competition binding
- Shown value from
- Wiley et al. 2024, Table 1
- Range
- 73–301 nM in 5 reports
This is the best-supported value. Other reports differ. 5 reports in all, 73–301 nM.
Sources and values behind the range, same assay family Report Value Where Wiley et al. 2024 163 nM Table 1 Husni et al. 2014 73 nM Table 1 Felder et al. 1995 301 nM Table 1 Rhee et al. 1997 126 nM Table 1 Munro et al. 1993 250 nM Results text (Figure 2b) Cannabigerol (CBG)490 nMZagzoog et al. 2020 · 6 reports
- Assay
- CHO membranes stably expressing human receptor; [3H]CP55,940 displacement; variable-slope four-parameter fit; independent experiments in duplicate
- Shown value from
- Zagzoog et al. 2020, Table 1
- Range
- 205–2919 nM in 6 reports
Reported values disagree and no value is established. 6 reports in all, 205–2919 nM.
Sources and values behind the range, same assay family Report Value Where Husni et al. 2014 2919 nM Table 1 Zagzoog et al. 2020 490 nM Table 1 Navarro et al. 2020 1225 nM, 2656 nM, 205 nM Table 1, Table 2 Cascio et al. 2010 2600 nM Figure 6 legend Cannabidiol (CBD)2370 nMWiley et al. 2024 · 6 reports
- Assay
- HEK293 membranes expressing human CB2; [3H]CP55,940 competition binding
- Shown value from
- Wiley et al. 2024, Table 1
- Range
- 240–4582 nM in 6 reports
This is the best-supported value. Other reports differ. 6 reports in all, 240–4582 nM.
Sources and values behind the range, same assay family Report Value Where Wiley et al. 2024 2370 nM Table 1 Husni et al. 2014 4582 nM Table 1 Zagzoog et al. 2020 240 nM Table 1 Navarro et al. 2020 1714 nM, 4019 nM, 705 nM Table 1, Table 2
Mouse
2 measurements
WIN 55,212-24.9 nMGovaerts SophieJ et al. 2004
- Assay
- mouse spleen membranes, [3H]CP 55,940 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
HU-21056 nMGovaerts SophieJ et al. 2004
- Assay
- mouse spleen membranes, [3H]CP 55,940 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
Rat
2 measurements
WIN 55,212-21.8 nMGovaerts SophieJ et al. 2004
- Assay
- rat spleen membranes, [3H]CP 55,940 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
HU-21045 nMGovaerts SophieJ et al. 2004
- Assay
- rat spleen membranes, [3H]CP 55,940 displacement
- Shown value from
- Govaerts SophieJ et al. 2004, Table 2
Unspecified
1 measurement
JWH-0182.9 nMBanister et al. 2015
- Assay
- literature binding value as compiled in Table S8, original assay of Aung 2000 (Drug Alcohol Depend 60:133)
- Shown value from
- Banister et al. 2015, Table S8 (Supporting Information)
Functional potency (EC₅₀)
9 substances, 9 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
9 measurements
HU-2100.50 nMRyberg et al. 2007
- Assay
- HEK293 membranes expressing human CB2, [35S]GTPgammaS binding
- Shown value from
- Ryberg et al. 2007, Table 1
- Error
- ± 0.10 SEM, n = 5
- Emax
- 99.0 ± 6.0%
CP 55,94036 nMScott et al. 2019 · 2 reports
- Assay
- Membranes of HEK293T cells expressing human CB2; [35S]GTPγS binding
- Shown value from
- Scott et al. 2019, Table 1
- Range
- 0.30–36 nM in 2 reports
- Error
- ± 26 SEM, n = 3
Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 0.30–560 nM.
Sources and values behind the range, same assay family Report Value Where Scott et al. 2019 36 nM Table 1 Ryberg et al. 2007 0.30 nM Table 1 Cannabidiol (CBD)58 nMZagzoog et al. 2020
- Assay
- PathHunter CHO cells stably expressing human receptor; beta-arrestin2 recruitment for 90 min; variable-slope four-parameter fit; independent experiments in triplicate
- Shown value from
- Zagzoog et al. 2020, Table 3
- Emax
- 23.0 ± 2.8%
WIN 55,212-262 nMBanister et al. 2015
- Assay
- mouse AtT-20 cells stably expressing human CB2, FLIPR membrane-potential/GIRK assay
- Shown value from
- Banister et al. 2015, Table 1
Cannabigerol (CBG)130 nMZagzoog et al. 2020
- Assay
- HitHunter CHO cells stably expressing human receptor; inhibition of forskolin-stimulated cAMP for 90 min; variable-slope four-parameter fit; independent experiments in triplicate
- Shown value from
- Zagzoog et al. 2020, Table 2
- Emax
- 39.0 ± 11.0%
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 130–1158 nM.
JWH-018133 nMBanister et al. 2015
- Assay
- mouse AtT-20 cells stably expressing human CB2, FLIPR membrane-potential/GIRK assay
- Shown value from
- Banister et al. 2015, Table 1
- Emax
- 95.0 ± 5.0%
Cannabinol (CBN)289 nMHusni et al. 2014
- Assay
- HEK293 cells expressing human CB2 membranes; [35S]GTPγS functional assay
- Shown value from
- Husni et al. 2014, Table 1
Δ⁸-THC (Tetrahydrocannabinol)524 nMHusni et al. 2014
- Assay
- HEK293 cells expressing human CB2 membranes; [35S]GTPγS functional assay
- Shown value from
- Husni et al. 2014, Table 1
Δ⁹-THC (Tetrahydrocannabinol)1157 nMBanister et al. 2015
- Assay
- mouse AtT-20 cells stably expressing human CB2, FLIPR membrane-potential/GIRK assay
- Shown value from
- Banister et al. 2015, Table 1
- Emax
- 13.0%
This is the best-supported value. Other reports differ. 5 reports in all, 0.40–1157 nM.
Also reported to act here
Substances reported to act here, without a displayed value.
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.